Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

archifiction-inc.com

Stage

Series A | Alive

About ArchiFiction

ArchiFiction aims to express an alternate architectural reality that is nonetheless based on the physical qualities of real objects and their representation. This project combines assembly strategies with video projection as means of augmenting architecture's sensual power while obfuscating the singular reading of an object.

ArchiFiction Headquarters Location

6th Floor, Building D-1, No. 2959, Yuhangtang Road, Hangzhou Future Science and Technology City

Hangzhou, Zhejiang ,

China

0571-26278507

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

ArchiFiction Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ArchiFiction Rank

  • Where is ArchiFiction's headquarters?

    ArchiFiction's headquarters is located at 6th Floor, Building D-1, No. 2959, Yuhangtang Road, Hangzhou Future Science and Technology City, Hangzhou.

  • What is ArchiFiction's latest funding round?

    ArchiFiction's latest funding round is Series A.

  • Who are the investors of ArchiFiction?

    Investors of ArchiFiction include Boton Technology, Tisiwi Ventures, Chengluo and Plug and Play China.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.